Jeffrey Hung

Stock Analyst at Morgan Stanley

(0)
# 4760
Out of 5,370 analysts
260
Total ratings
35.14%
Success rate
-17.19%
Average return
42 Stocks
Name Action PT Current % Upside Ratings Updated
ACAD ACADIA Pharmaceutica...
Maintains: Equal-Weight
20 24
22.12 8.5% 25 May 20, 2025
CTNM Contineum Therapeuti...
Maintains: Overweight
25 20
4.29 366.2% 3 May 19, 2025
CGON CG Oncology
Maintains: Overweight
55 52
25.41 104.64% 3 May 19, 2025
RARE Ultragenyx Pharmaceu...
Maintains: Overweight
64 65
37.03 75.53% 8 May 9, 2025
JAZZ Jazz Pharmaceuticals
Maintains: Overweight
183 166
109.64 51.4% 6 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
15 17
8.04 111.44% 5 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
37 34
3.29 933.43% 3 Mar 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
72 72
62.34 15.5% 11 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
67 70
51.79 35.16% 11 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
185 150
125.3 19.71% 24 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
4 4
1.41 183.69% 3 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
85
51.94 63.65% 6 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
38 35
8.75 300% 6 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
27 27
12.6 114.29% 2 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Underweight
5
4.37 14.42% 2 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
70 67
33.75 98.52% 13 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
17 12
6.05 98.35% 4 Dec 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
92 95
n/a n/a 5 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
35
7.24 383.43% 1 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
50 70
31.07 125.3% 2 May 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
295 330
n/a n/a 3 Dec 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
10 4
0.97 312.37% 10 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
13 4
7.87 -49.17% 1 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
1 4
0.8 400% 1 Dec 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
60 140
n/a n/a 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
14 14
2.36 493.22% 3 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
5 5
3.35 49.25% 1 Jul 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
9 3
1.17 156.41% 8 Mar 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
15 14
1.46 858.9% 7 Feb 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
42 21
n/a n/a 4 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
4 2
n/a n/a 3 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
50 10
1.81 452.49% 3 Jan 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
22 30
n/a n/a 6 Jan 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
23 22
41.74 -47.29% 10 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
2 2
n/a n/a 5 Sep 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
250 94
n/a n/a 8 Jul 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
146 149
15.15 880.2% 2 May 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
180
n/a n/a 12 Oct 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
100 60
1.78 3270.79% 5 Aug 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 6
3.31 81.27% 9 Apr 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
121 225
n/a n/a 9 Oct 6, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
58 54
0.5 10700% 6 May 8, 2020